Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

MM Incidence in Cardiothoracic Transplant Populace

JAMA Dermatology; ePub 2018 Feb 16; Puza, et al

Recent findings suggest that the cardiothoracic (heart and/or lung) transplant (CTT) population experiences an incidence of malignant melanoma (MM) similar to that of other solid organ transplant recipients and with a median of 2.5 years from transplant to melanoma diagnosis. This according to a retrospective cohort study of patients who underwent a CTT from 2001 through 2016 with a median follow-up time of 4.3 years. Researchers found:

  • 5 of 1,154 patients who underwent a CTT (0.4%) developed biopsy-proven MM at a median follow-up time of 4.3 years after transplantation at a median age of 64.5 years.
  • Of total patients, 923 (80%) were men.
  • Their mean (SD) age was 63.8 years (range, 27.2-68.2 years).
  • 4 patients (80%) presented with stage I disease while 1 (20%) presented with stage IV disease at a median time of 2.5 years after transplant compared with a median time of 6.2 years in a renal transplant population at a median follow-up time of 6.6 years.
  • 2 patients died after transplant, 1 owing to complications of the transplant and 1 owing to metastatic MM.
Citation:

Puza CJ, Cardones AR, Mosca PJ. Examining the incidence and presentation of melanoma in the cardiothoracic transplant population. [Published online ahead of print February 16, 2018]. JAMA Dermatology. doi:10.1001/jamadermatol.2018.0130.

This Week's Must Reads

Dermatomyositis, Negative ANA, and Malignancy Risk, J Am Acad Dermatol; ePub 2018 Nov 17; Hoesly, et al

Head/Neck Melanomas Have High Local Recurrence Risk, J Am Acad Dermatol; ePub 2018 Nov 17; Fix, et al

DOT Laser Offers Low Incidence of Adverse Effects, J Drugs Dermatol; 2018 Nov; Sarnoff, Gotkin, et al

Frontal Fibrosing Alopecia and Severity Factors , Dermatology (Karger); ePub 2018 Nov 22; Mervis, et al

Unsafe Neighborhoods Linked with Higher AD Risk, Ann Allergy Asthma Immunol; ePub 2018 Oct 26; McKenzie, et al

Must Reads in Melanoma

Head/Neck Melanomas Have High Local Recurrence Risk, J Am Acad Dermatol; ePub 2018 Nov 17; Fix, et al

Early Desmoplastic Melanoma Treatment Comparison, Melanoma Res; ePub 2018 Oct 31; Abbott, et al

Melanoma Risk and Moderately Dysplastic Nevi, JAMA Dermatol; ePub Oct 10; Kim, Berry, et al

Predictors of Mucosal Melanoma Survival, J Am Acad Dermatol; ePub 2018 Oct 5; Altieri, et al

Follicular Involvement Frequent in Lentigo Maligna, J Am Acad Dermatol; ePub 2018 Sep 26; Connolly, et al